Covered recipient · General Payments record
OLUFEMI J ABIODUN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$5,969.32
- Reported across 338 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $577.65 | 30 |
| Education | $33.80 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $261.14 | 20 |
| Pinnacle Biologics, Inc | $115.81 | 1 |
| Janssen Biotech, Inc. | $69.76 | 4 |
| Merck Sharp & Dohme Corporation | $68.57 | 3 |
| Celgene Corporation | $59.22 | 4 |
| Lilly USA, LLC | $18.70 | 1 |
| Sandoz Inc. | $18.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.21 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166784 | CMS |
| ABBVIE INC. | $6.36 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166786 | CMS |
| ABBVIE INC. | $18.77 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166788 | CMS |
| ABBVIE INC. | $16.60 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166790 | CMS |
| ABBVIE INC. | $3.93 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166792 | CMS |
| ABBVIE INC. | $14.51 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166794 | CMS |
| ABBVIE INC. | $7.37 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166796 | CMS |
| ABBVIE INC. | $7.18 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166798 | CMS |
| ABBVIE INC. | $23.43 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166800 | CMS |
| ABBVIE INC. | $15.11 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166802 | CMS |
| ABBVIE INC. | $24.20 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166804 | CMS |
| ABBVIE INC. | $8.45 | 07/22/2024 | Education | Undisputed | 01/23/2026 | 1104193846 | CMS |
| ABBVIE INC. | $12.03 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166806 | CMS |
| ABBVIE INC. | $8.45 | 09/06/2024 | Education | Undisputed | 01/23/2026 | 1104193848 | CMS |
| ABBVIE INC. | $13.72 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166808 | CMS |
| ABBVIE INC. | $17.54 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166810 | CMS |
| ABBVIE INC. | $19.75 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166812 | CMS |
| ABBVIE INC. | $8.45 | 11/04/2024 | Education | Undisputed | 01/23/2026 | 1104193850 | CMS |
| ABBVIE INC. | $8.45 | 11/18/2024 | Education | Undisputed | 01/23/2026 | 1104193852 | CMS |
| ABBVIE INC. | $7.63 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103166814 | CMS |
| Celgene Corporation | $14.38 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101119163 | CMS |
| Celgene Corporation | $13.50 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101119167 | CMS |
| Celgene Corporation | $17.59 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101119173 | CMS |
| Celgene Corporation | $13.75 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101119177 | CMS |
| Janssen Biotech, Inc. | $18.35 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078682462 | CMS |
| Janssen Biotech, Inc. | $18.46 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078682882 | CMS |
| Janssen Biotech, Inc. | $15.42 | 09/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078683026 | CMS |
| Janssen Biotech, Inc. | $17.53 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078682554 | CMS |
| Lilly USA, LLC | $18.70 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135261297 | CMS |
| Merck Sharp & Dohme LLC | $19.86 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141599543 | CMS |
| Merck Sharp & Dohme LLC | $24.44 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141599371 | CMS |
| Merck Sharp & Dohme LLC | $24.27 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141599373 | CMS |
| Pinnacle Biologics, Inc | $115.81 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132919557 | CMS |
| Sandoz Inc. | $18.25 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089365939 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.